Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin
Open Access
- 19 June 2007
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 97 (2) , 201-209
- https://doi.org/10.1038/sj.bjc.6603856
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Delineation of Matriptase Protein Expression by Enzymatic Gene Trapping Suggests Diverging Roles in Barrier Function, Hair Formation, and Squamous Cell CarcinogenesisThe American Journal of Pathology, 2006
- Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progressionHead & Neck, 2005
- Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformationGenes & Development, 2005
- Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivityBiochemical Journal, 2005
- Mouse DESC1 Is Located within a Cluster of Seven DESC1-like Genes and Encodes a Type II Transmembrane Serine Protease That Forms Serpin Inhibitory ComplexesJournal of Biological Chemistry, 2004
- Hepsin promotes prostate cancer progression and metastasisCancer Cell, 2004
- Type II transmembrane serine proteasesThrombosis and Haemostasis, 2003
- Building epithelial architecture: insights from three-dimensional culture modelsNature Reviews Molecular Cell Biology, 2002
- Functional characterization of MT3‐MMP in transfected MDCK cells: progelatinase A activation and tubulogenesis in 3‐D collagen latticeThe FASEB Journal, 2000
- Membrane Type 1-Matrix Metalloproteinase Is Involved in the Formation of Hepatocyte Growth Factor/Scatter Factor-Induced Branching Tubules in Madin-Darby Canine Kidney Epithelial CellsBiochemical and Biophysical Research Communications, 1998